S0D7V00ZRX 84937-45-1 Gusperimus (-)-form trihydrochloride Gusperimus hydrochloride Gusperimus Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride, (-)- Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride, (S)- Heptanamide, 7-((aminoiminomethyl)amino)-N-((1S)-2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride (-)-(15S)-1-Amino-19-guanidino-11,15-dihydroxy-4,9,12-triazanonadecane-10,13-dione 3HCl (-)-15-Deoxyspergualin trihydrochloride Gusperimus HCl UNII-S0D7V00ZRX Deoxyspergualin trihydrochloride (-)-Gusperimus trihydrochloride CAS 84937-45-1
| CAS No. | 84937-45-1 |
| Molecular Formula | C17H37N7O3 |
| Molecular Weight | N/A |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including S0D7V00ZRX 84937-45-1 Gusperimus (-)-form trihydrochloride Gusperimus hydrochloride Gusperimus Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride, (-)- Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride, (S)- Heptanamide, 7-((aminoiminomethyl)amino)-N-((1S)-2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride (-)-(15S)-1-Amino-19-guanidino-11,15-dihydroxy-4,9,12-triazanonadecane-10,13-dione 3HCl (-)-15-Deoxyspergualin trihydrochloride Gusperimus HCl UNII-S0D7V00ZRX Deoxyspergualin trihydrochloride (-)-Gusperimus trihydrochloride.
CATO supplies S0D7V00ZRX 84937-45-1 Gusperimus (-)-form trihydrochloride Gusperimus hydrochloride Gusperimus Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride, (-)- Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride, (S)- Heptanamide, 7-((aminoiminomethyl)amino)-N-((1S)-2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride (-)-(15S)-1-Amino-19-guanidino-11,15-dihydroxy-4,9,12-triazanonadecane-10,13-dione 3HCl (-)-15-Deoxyspergualin trihydrochloride Gusperimus HCl UNII-S0D7V00ZRX Deoxyspergualin trihydrochloride (-)-Gusperimus trihydrochloride (CAS 84937-45-1), a certified reference material (molecular formula C17H37N7O3HCl, MW 423.99 g/mol) for analytical method development and quality control.
Owing to an amide group, a carboxylic acid group, a hydroxyl group, an ether linkage, chlorine substitution, S0D7V00ZRX 84937-45-1 Gusperimus (-)-form trihydrochloride Gusperimus hydrochloride Gusperimus Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride, (-)- Heptanamide, 7-((aminoiminomethyl)amino)-N-(2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride, (S)- Heptanamide, 7-((aminoiminomethyl)amino)-N-((1S)-2-((4-((3-aminopropyl)amino)butyl)amino)-1-hydroxy-2-oxoethyl)-, trihydrochloride (-)-(15S)-1-Amino-19-guanidino-11,15-dihydroxy-4,9,12-triazanonadecane-10,13-dione 3HCl (-)-15-Deoxyspergualin trihydrochloride Gusperimus HCl UNII-S0D7V00ZRX Deoxyspergualin trihydrochloride (-)-Gusperimus trihydrochloride is typically white to off-white crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 423.99 g/mol — guide the selection of appropriate sample preparation and analytical techniques. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
Physical & Chemical Properties
| Molecular Formula | C17H37N7O3 3*HCl |
| Molecular Weight | 423.99 g/mol |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 2.0 |
| CAS Registry Year (est.) | 1981 |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 7 |
Recommended Standards
- Methyl 6-dimethoxyphosphoryl-5-oxo-hexanoate (CAS 104227-38-5)
- 3-(Chloromethyl)-7-cyclopropyl-[1,2,4]triazolo[4,3-a]pyrazin-8(7H)-one (CAS 1707375-69-6)
- Sorafenib related compound 26 (CAS 573673-43-5)
- 2-Bromo-N-isopropylbutanamide (CAS 41643-82-7)
- 2-AMINO-5-BROMO-3-CYANOPYRIDINE 2-AMINO-5-BROMO-3-PYRIDINECARBONITRILE 2-AMINO-5-BROMONICOTINONITRILE 2-AMINO-5-BROMOPYRIDINE-3-CARBONITRILE 709652-82-4 ABBYPHARMA AP-18-5662 BC004069 (CAS 709652-82-4)
- 4-(4-Fluorophenyl)-5-phenyl-4h-1,2,4-triazole-3-thiol (CAS 120873-34-9)
- 2-Bromo-N-(4-methyl-5-oxo-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepin-7-yl)benzamide (CAS 922000-88-2)
- 2,4-Dibromo-1H-benzo[d]imidazole (CAS 1379312-49-8)
- Pyridin-3-yl(tetrahydro-2H-pyran-4-yl)methanamine dihydrochloride (CAS 2068152-05-4)
- Dendroaspis Natriuretic Peptide (CAS 255721-52-9)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com